Atovaquone — a novel broad-spectrum anti-infective drug
- 1 February 1993
- journal article
- Published by Elsevier in Parasitology Today
- Vol. 9 (2), 66-68
- https://doi.org/10.1016/0169-4758(93)90040-m
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDSThe Lancet, 1992
- Fourth malaria meetingParasitology Today, 1992
- A Preliminary Evaluation of 566C80 for the Treatment of Pneumocystis Pneumonia in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991
- Evaluation of the Effect of Drugs on the Cyst Form of Toxoplasma gondiiThe Journal of Infectious Diseases, 1991
- Safety and Pharmacokinetics of 566C80, a Hydroxynaphthoquinone with Anti-Pneumocystis carinii Activity: A Phase I Study in Human Immunodeficiency Virus (HIV)-Infected MenThe Journal of Infectious Diseases, 1991
- Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activityParasitology, 1985
- Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitroMolecular and Biochemical Parasitology, 1985
- Conversion of dihydroorotate to orotate in parasitic protozoaBiochimica et Biophysica Acta (BBA) - General Subjects, 1979
- Naphthoquinone Antimalarials. XXIX. 2-Hydroxy-3-(ω-cyclohexylalkyl)-1,4-naphthoquinonesJournal of Medicinal Chemistry, 1967
- Naphthoquinone Antimalarials. II. Correlation of Structure and Activity Against P. lophurae in Ducks1Journal of the American Chemical Society, 1948